Dr. Michael Gazzaniga

Dr. Michael Gazzaniga
Dr. Michael Gazzaniga is a board-certified urologist of Southland Urology. He is a native Southern Californian. He attended medical school at Dartmouth Medical in Hanover, New Hampshire. In 1996, he returned to California and completed his residency in Urology at UC Irvine Medical Center. While on staff at UC Irvine he served as a clinical instructor to residents. Since joining Southland Urology in 2002 Dr. Gazzaniga has been the recipient of Orange Coast Magazine’s “Physician of Excellence” award, as voted on by his peers within the Orange County Medical Association. He has received this distinction from 2006 to 2020. He has published articles on topics that include laparoscopic surgery and prostate cancer. He has served as Chief of Surgery and was director of the Urologic Oncology division at St Jude Medical Center. He belongs to the Orange County Urological Society, OCMA, and is a member of the AMA. He has volunteered multiple years to Access OC which provides free surgical care to the uninsured. Dr. Gazzaniga has done many lectures throughout Orange County and nationally on topics that include Robotic Surgery and neuromodulation of urological disorders. He has traveled throughout the United States as an instructor teaching other surgeons surgical techniques in neuromodulation.
Medical School:

Dartmouth Medical, Hanover, New Hampshire

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only